Key Highlights
- That Marketing Solution was founded in 2012 and develops, manufactures, and markets nutritional supplements, most notably Low-T capsules for testosterone support.
- Aggregated data list roughly 1.28 billion shares outstanding against a market Capitalization of only about $1,300.
- A historical net loss running into the millions of dollars has been cited, with the company reporting only a couple of employees.
- No identifiable public catalyst explains any recent movement in the stock.
That Marketing Solution, Inc. (OTC:TSTS) is the kind of ticker that rarely surfaces in mainstream market coverage: a tiny, development-stage consumer-products shell whose shares change hands, when they trade at all, at a fraction of a cent.
Company and Latest Development
That Marketing Solution, Inc. was founded in 2012 and is registered as a development-stage company in the consumer staples space, specifically household and personal products. Its publicly described Business centers on the development, manufacturing, Advertising and marketing of nutritional supplements, most notably a line called Low-T capsules, a non-FDA-regulated, over-the-counter supplement marketed toward testosterone support in men over 30.
The company reports a minimal footprint, with only a couple of employees, and no recent operational news has surfaced in public aggregators, leaving the latest verifiable picture one of a micro-cap consumer Brand with limited disclosure.
What Is Driving Attention Around TSTS?
Very little. There is no identifiable public catalyst behind any recent movement in the stock, and the price sits pinned near the absolute floor of $0.000001. At a market capitalization measured in the low four figures, TSTS trades as a nano-cap where a handful of shares can distort quoted prices.
Attention, to the extent it exists, is driven by the stock's Placement on speculative watchlists and sub-penny screeners, not by fundamental news.
Key Numbers and Company Position
Verifiable figures are sparse and should be treated cautiously given the company's limited reporting. Aggregated data list roughly 1.28 billion shares outstanding against a market capitalization of only about $1,300, consistent with a quoted price at the very bottom of the scale.
A historical net loss running into the millions of dollars has been cited, underscoring that the business has not demonstrated sustained profitability. With so few employees and no reported Revenue momentum, the company's position is best described as dormant to early-stage.
What Could Come Next?
For a shell-like consumer micro-cap, the meaningful near-term events are administrative rather than commercial: whether the company files updated financials, maintains its transfer-agent and OTC reporting status, refreshes its product marketing, or pursues a Reverse merger or recapitalization, a common path for dormant sub-penny tickers.
Any renewed disclosure would be the first step toward re-establishing a genuine Investment narrative.
Risks to Watch
The risks here are severe and characteristic of the sub-penny tier. Extremely thin Liquidity means quoted prices can be unreliable and positions difficult to exit. Limited or delayed public reporting raises transparency concerns.
Nano-caps at this level face a real risk of becoming fully dormant, having their quotes flagged or restricted, or diluting holders through new share issuance.
A Supplement Line With Almost No Market Behind It
That Marketing Solution, Inc. is less a live investment story than a dormant development-stage consumer shell whose shares sit at the floor of the pricing scale. The inactivity reflects near-total dormancy, not stability born of strength, and no public catalyst explains recent trading.
Investors who encounter TSTS may want to monitor whether the company resumes meaningful disclosure, updates its Low-T supplement efforts, or signals any strategic transaction.






Please wait processing your request...